BIOL 304 6380 Routine cancer screenings are recommended by physicians and medical practitioners to inform patients who might have pre-dispositions or early signs of cancer

BIOL 304 6380 Routine cancer screenings are recommended by physicians and medical practitioners to inform patients who might have pre-dispositions or early signs of cancer

BIOL 304 6380 Routine cancer screenings are recommended by physicians and medical practitioners to inform patients who might have pre-dispositions or early signs of cancer

Discussion: Cancer Screening

Routine cancer screening can help detect cancer at an early stage when the patient is asymptomatic. Identification of the cancerous cells at an early stage help promote better disease prognosis among patient who seeks timely medical interventions (Barba et al., 2021). When the patient starts preventing symptoms, the cancer is usually in the advanced stages, and even metastasized in the body, making it hard to manage. Routine screening tests are also crucial in staging the patient’s cancer and evaluating the treatment outcome for necessary alterations. Cancer staging helps determine the prognosis of the patient.

What information does staging provide regarding the prognosis of a patient?

Studies show that the survival rate or prognosis of most types of cancer is mainly based on the staging at the time when the patient’s diagnosis was confirmed (Xu et al., 2020). Cancer staging can be done at different times, depending on the information required. For instance, in clinical staging, the extent to which cancer has developed can be determined based on imaging studies, physical examination, biopsies, and endoscopy, giving an idea of the patient’s prognosis. Pathological staging is done before surgery for patients whose first initial therapeutic intervention is the removal of the cancerous cells. This helps in providing precise information that can be used to predict treatment outcomes and patient responses. Recurrent staging is also crucial in monitoring the progress of cancer.

Some cancer screenings have risks associated with them.  Do you think the benefits of the screenings outweigh the risks?   

Several cancer screening tests are available, with the benefits of most of them having been proven as the benefits to

BIOL 304 6380 Routine cancer screenings are recommended by physicians and medical practitioners to inform patients who might have pre-dispositions or early signs of cancer
BIOL 304 6380 Routine cancer screenings are recommended by physicians and medical practitioners to inform patients who might have pre-dispositions or early signs of cancer

others and to be well known. However, before deciding on which screening test to use, it is important to ensure that the benefits outweigh the risks. For instance, routine cancer screening among the high-risk population is important in promoting early detection and timely treatment for a better prognosis (van den Ende et al., 2017). Screening also helps monitor the progress of cancer and determine the best treatment approaches that can help promote the patient’s health. The main limitation of cancer screening is associated with the findings, like the false negative and false positive. As such, it is clear that the benefits of cancer screenings outweigh the risks.

 

Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: BIOL 304 6380 Routine cancer screenings are recommended by physicians and medical practitioners to inform patients who might have pre-dispositions or early signs of cancer

References

Barba, D., León-Sosa, A., Lugo, P., Suquillo, D., Torres, F., Surre, F., Trojman, L., & Caicedo, A. (2021). Breast cancer, screening, and diagnostic tools: All you need to know. Critical Reviews in Oncology/Hematology157, 103174. https://doi.org/10.1016/j.critrevonc.2020.103174

van den Ende, C., Oordt-Speets, A. M., Vroling, H., & van Agt, H. M. E. (2017). Benefits and harms of breast cancer screening with mammography in women aged 40-49 years: A systematic review. International Journal of Cancer141(7), 1295–1306. https://www.doi.org/10.1002/ijc.30794

Xu, Q., Yuan, J.-P., Chen, Y.-Y., Zhang, H.-Y., Wang, L.-W., & Xiong, B. (2020). Prognostic Significance of the Tumor-Stromal Ratio in Invasive Breast Cancer and a Proposal of a New Ts-TNM Staging System. Journal of Oncology2020, 1–10. https://doi.org/10.1155/2020/9050631